BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10480437)

  • 1. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients.
    Galotto M; Berisso G; Delfino L; Podesta M; Ottaggio L; Dallorso S; Dufour C; Ferrara GB; Abbondandolo A; Dini G; Bacigalupo A; Cancedda R; Quarto R
    Exp Hematol; 1999 Sep; 27(9):1460-6. PubMed ID: 10480437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment.
    Banfi A; Bianchi G; Galotto M; Cancedda R; Quarto R
    Leuk Lymphoma; 2001; 42(5):863-70. PubMed ID: 11697641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the functional capacity of marrow stromal cells after autologous bone marrow transplantation.
    Domenech J; Roingeard F; Hérault O; Truglio D; Desbois I; Colombat P; Binet C
    Leuk Lymphoma; 1998 May; 29(5-6):533-46. PubMed ID: 9643567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
    Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
    J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
    Domenech J; Linassier C; Gihana E; Dayan A; Truglio D; Bout M; Petitdidier C; Delain M; Petit A; Brémond JL
    Blood; 1995 Jun; 85(11):3320-7. PubMed ID: 7756665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM; Jones M; Levy RB
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
    Zecca M; Pession A; Messina C; Bonetti F; Favre C; Prete A; Cesaro S; Porta F; Mazzarino I; Giorgiani G; Rondelli R; Locatelli F
    J Clin Oncol; 1999 Jun; 17(6):1838-46. PubMed ID: 10561223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.
    Raiola AM; Dominietto A; Ghiso A; Di Grazia C; Lamparelli T; Gualandi F; Bregante S; Van Lint MT; Geroldi S; Luchetti S; Ballerini F; Miglino M; Varaldo R; Bacigalupo A
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):117-22. PubMed ID: 22940057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of hemopoietic stromal progenitor cells after lethal total-body irradiation and bone marrow transplantation in mice.
    Piersma AH; Brockbank KG; Ploemacher RE; Ottenheim CP
    Transplantation; 1985 Aug; 40(2):198-201. PubMed ID: 2862723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia.
    Banfi A; Podestà M; Fazzuoli L; Sertoli MR; Venturini M; Santini G; Cancedda R; Quarto R
    Cancer; 2001 Nov; 92(9):2419-28. PubMed ID: 11745299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells.
    Lee WY; Cho SW; Oh ES; Oh KW; Lee JM; Yoon KH; Kang MI; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    J Clin Endocrinol Metab; 2002 Jan; 87(1):329-35. PubMed ID: 11788670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term bone marrow cultures established from bone marrow transplant recipients.
    Treweeke AT; Hampson J; Clark RE
    Leuk Lymphoma; 1993 Dec; 12(1-2):117-22. PubMed ID: 8161928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells.
    Schwartz GN; Warren MK; Rothwell SW; Zujewski J; Halverson DC; Cowan KH; Tolcher A; O'Shaughnessy J; Gress RE
    Bone Marrow Transplant; 1998 Sep; 22(5):457-68. PubMed ID: 9733269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between regimens containing chemotherapy alone (busulfan and cyclophosphamide) and chemotherapy (V. RAPID) plus total body irradiation on marrow engraftment following allogeneic bone marrow transplantation.
    Reynolds M; McCann SR
    Eur J Haematol; 1989 Oct; 43(4):314-20. PubMed ID: 2684682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation.
    Lawton CA; Cohen EP; Murray KJ; Derus SW; Casper JT; Drobyski WR; Horowitz MM; Moulder JE
    Bone Marrow Transplant; 1997 Dec; 20(12):1069-74. PubMed ID: 9466280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of continuous gamma-radiation at low doses on clonogenic hemopoietic (CFU-S) and stromal (CFU-F) bone marrow cells ].
    Domaratskaia EI; Starostin VI; Tsetlin VV; Butorina NN; Bueverova EI; Bragina EV; Khrushchov NG
    Izv Akad Nauk Ser Biol; 2002; (4):402-6. PubMed ID: 12180004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.